Jordi Remon
28PUBLICATIONS
152CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (28)
Sort by Publication Date:
|Apr 08, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026.Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo
|Apr 07, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP Registry.Arianna Marinello, Julia K Rotow, Meghanne Lomibao
|Jan 22, 2026
BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non-Small Cell Lung Cancer.Jordi Remon, Tina Cascone, Solange Peters
|Dec 12, 2025
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.Oscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia
|Oct 09, 2025
Unresectable stage III non-small-cell lung cancer: state of the art and challenges.Jordi Remon, Antonin Levy, Romane Gille
|May 16, 2025
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.Oscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia
Pageof 5
Frequent Collaborators
7 joint publications
Lizza Hendriks
7 joint publications
Benjamin Besse
4 joint publications
Mihaela Aldea
3 joint publications
David Planchard
3 joint publications
Oscar Arrieta
2 joint publications
Anne-Marie C Dingemans
2 joint publications
Javier De Castro
2 joint publications
Jarushka Naidoo
2 joint publications
Noemi Reguart
2 joint publications
Lodovica Zullo
